- Home
- APLT vs NRT Comparison
APLT vs NRT Comparison
Compare APLT & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- NRT
- Stock Information
- Founded
- APLT 2016
- NRT 1975
- Country
- APLT United States
- NRT United States
- Employees
- APLT N/A
- NRT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- NRT Oil & Gas Production
- Sector
- APLT Health Care
- NRT Energy
- Exchange
- APLT Nasdaq
- NRT Nasdaq
- Market Cap
- APLT 37.5M
- NRT 44.0M
- IPO Year
- APLT 2019
- NRT N/A
- Fundamental
- Price
- APLT $0.35
- NRT $5.18
- Analyst Decision
- APLT Buy
- NRT
- Analyst Count
- APLT 7
- NRT 0
- Target Price
- APLT $6.10
- NRT N/A
- AVG Volume (30 Days)
- APLT 1.4M
- NRT 37.1K
- Earning Date
- APLT 08-06-2025
- NRT 05-30-2025
- Dividend Yield
- APLT N/A
- NRT 9.07%
- EPS Growth
- APLT N/A
- NRT 24.05
- EPS
- APLT N/A
- NRT 0.59
- Revenue
- APLT $265,000.00
- NRT $6,184,173.00
- Revenue This Year
- APLT $1,768.13
- NRT N/A
- Revenue Next Year
- APLT $292.85
- NRT N/A
- P/E Ratio
- APLT N/A
- NRT $8.83
- Revenue Growth
- APLT N/A
- NRT 18.55
- 52 Week Low
- APLT $0.30
- NRT $3.88
- 52 Week High
- APLT $10.62
- NRT $6.90
- Technical
- Relative Strength Index (RSI)
- APLT 42.17
- NRT 57.49
- Support Level
- APLT $0.34
- NRT $5.05
- Resistance Level
- APLT $0.38
- NRT $5.45
- Average True Range (ATR)
- APLT 0.02
- NRT 0.20
- MACD
- APLT -0.00
- NRT -0.01
- Stochastic Oscillator
- APLT 7.14
- NRT 52.24
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.